What is SION's change in AP?

SION (SION) reported change in AP of $1.21M in Q1 2026.

How has SION's change in AP changed year-over-year?

SION's change in AP decreased by 66.0% year-over-year, from $3.55M to $1.21M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

SION SION Change in AP

Change in AP at other companies

Vertex PharmaceuticalsVRTX

$35.6M+35.9%

AbbVieABBV

-$1.59B-129%

Septerna, Inc.SEPN

-$2.3M-294%

BioCryst PharmaceuticalsBCRX

-$60.4M-85.3%

Denali Therapeutics Inc.DNLI

$3.88M+247%

Neurocrine BiosciencesNBIX

-$14.3M-377%

Other financials

Income statement

See full

Operating income-$29.6M-50.6%

Net income-$26.8M-62.5%

EPS (diluted)-$0.60+3.2%

Balance sheet

See full

Cash & equivalents$64.3M-23.2%

Total debt$8.4M-11.8%

Total equity$288.2M-18.1%

Total assets$305.0M-17.5%

Cash flow

See full

Operating cash flow-$21.8M-34.1%

CapEx--100%

Free cash flow-$21.8M-33.4%

Valuation

See full

Market cap$1.86B—

Returns & leverage

See full

Return on equity-26.7%—

Debt / equity0×0.0×

Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SION's change in AP?: SION (SION) reported change in AP of $1.21M in Q1 2026.
How has SION's change in AP changed year-over-year?: SION's change in AP decreased by 66.0% year-over-year, from $3.55M to $1.21M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.